Ovid Therapeutics Inc (OVID)

07:40 AM

Ovid Therapeutics (OVID): HC Wainwright Raises Price Target to $2.00 | OVID Stock News - GuruFocus

07:40 AM

Nov 21, 2025

Ovid CEO Meg Alexander Takes The Helm In Time To Harvest Growing Blooms - Citeline News & Insights

Nov 21, 2025

Nov 21, 2025

Is Ovid Therapeutics Inc. stock overvalued by current metricsJuly 2025 Highlights & Real-Time Market Sentiment Alerts - newser.com

Nov 21, 2025

Nov 20, 2025

Visual trend scoring systems applied to Ovid Therapeutics Inc.Earnings Risk Summary & Detailed Earnings Play Alerts - newser.com

Nov 20, 2025

Nov 19, 2025

Will Ovid Therapeutics Inc. (1OT) stock see valuation expansionWeekly Stock Report & Step-by-Step Swing Trade Plans - newser.com

Nov 19, 2025

Nov 19, 2025

What consensus target says about Ovid Therapeutics Inc. (1OT) stock2025 Growth vs Value & Risk Managed Investment Entry Signals - newser.com

Nov 19, 2025

Nov 19, 2025

Is Ovid Therapeutics Inc. stock cheap at current valuation2025 Market Outlook & Expert Curated Trade Setups - newser.com

Nov 19, 2025

Nov 19, 2025

Regression analysis insights on Ovid Therapeutics Inc. performanceDollar Strength & High Yield Equity Trading Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Ovid Therapeutics Reports Q3 2025 Financial Results - MSN

Nov 19, 2025

Nov 19, 2025

Combining machine learning predictions for Ovid Therapeutics Inc. - newser.com

Nov 19, 2025

Nov 19, 2025

Long term hold vs stop loss in Ovid Therapeutics Inc.2025 Short Interest & Community Trade Idea Sharing - newser.com

Nov 19, 2025

Nov 19, 2025

Historical volatility pattern of Ovid Therapeutics Inc. visualizedWeekly Investment Summary & Free High Accuracy Swing Entry Alerts - newser.com

Nov 19, 2025

Nov 17, 2025

Leerink Partners Initiates Coverage of Ovid Therapeutics (OVID) with Outperform Recommendation - Nasdaq

Nov 17, 2025

Nov 17, 2025

This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Nov 17, 2025

Nov 17, 2025

OVID: Leerink Partners Initiates Coverage with 'Outperform' Rati - GuruFocus

Nov 17, 2025

Nov 17, 2025

Leerink Partners Initiates Ovid Therapeutics at Outperform With $5 Price Target - MarketScreener

Nov 17, 2025

Nov 17, 2025

Can trapped investors hope for a rebound in Ovid Therapeutics Inc.2025 Market Sentiment & Daily Stock Trend Reports - newser.com

Nov 17, 2025

Nov 17, 2025

Ovid Therapeutics (OVID) Receives Positive Outlook from Analyst - GuruFocus

Nov 17, 2025

Nov 17, 2025

How Ovid Therapeutics Inc. (1OT) stock correlates with oil marketsMarket Activity Report & Consistent Profit Trading Strategies - newser.com

Nov 17, 2025

Nov 16, 2025

Published on: 2025-11-16 07:02:40 - newser.com

Nov 16, 2025

Nov 15, 2025

Price to book ratio of Ovid Therapeutics Inc. – HAM:1OT - TradingView

Nov 15, 2025

Nov 14, 2025

Published on: 2025-11-14 21:11:45 - newser.com

Nov 14, 2025

Nov 14, 2025

Is Ovid Therapeutics Inc. (1OT) stock protected from inflationWeekly Profit Summary & Real-Time Buy Signal Notifications - newser.com

Nov 14, 2025

Nov 14, 2025

Is Ovid Therapeutics Inc. stock oversold or undervaluedPortfolio Update Report & Community Driven Trade Alerts - Fundação Cultural do Pará

Nov 14, 2025

Nov 13, 2025

Ovid Therapeutics Draws Strong Buy Ratings After Q3 Earnings Update - Finimize

Nov 13, 2025